Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$1.98 - $2.42 $233 - $285
-118 Reduced 0.14%
86,968 $206,000
Q2 2022

Aug 12, 2022

BUY
$2.21 - $2.7 $39 - $48
18 Added 0.02%
87,086 $197,000
Q2 2021

Aug 06, 2021

BUY
$3.43 - $3.96 $343 - $396
100 Added 0.11%
87,068 $337,000
Q4 2019

Feb 07, 2020

BUY
$2.74 - $4.2 $238,292 - $365,265
86,968 New
86,968 $286,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0

About Theratechnologies Inc.


  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $114M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.